- Home
- Profile
- Services
-
Name Patient SupplyFDA Approved
-
Medical Oncology
-
Lung Cancer
- Alecensa (alectinib)
- Alimta (Pemetrexed)
- Alunbrig (Brigatinib)
- Avastin (bevacizumab)
- Crizalk (Crizotinib)
- Cyendiv (nintedanib)
- Erlonat (Erlotinib)
- Geftinat (Gefitinib)
- Gilotrif (Afatinib)
- Hycamtin (Topotecan)
- Imfinzi (durvalumab)
- Lorbrena (Lorlatinib)
- Mekinist (Trametinib)
- Ofev (Nintedanib)
- Pemnat (Pemetrexed)
- Portrazza (Necitumumab)
- Tagrisso (Osimertinib)
- Tafinlar (dabrafenib)
- Vargatef (nintedanib)
- Vizimpro (dacomitinib)
- Prostate Cancer
- Thyroid cancer
- Breast cancer
- Soft Tissue Sarcoma
- Colorectal Cancer
- Ovarian cancer
- Pancreatic cancer
- Liver Cancer
- Adrenal cortical carcinoma
- Idiopathic pulmonary fibrosis
- Stomach Cancer
-
Lung Cancer
-
Haemto Oncology
-
Multiple Melanoma
- Alkeran (Melphalan)
- Bortenat (bortezomib)
- Bosulif (Bosutinib)
- Braftovi (Encorafenib)
- Calquence (Acalabrutinib)
- Darzalex (Daratumumab)
- Defitelio (Difibrotide)
- Eldisine (Vindesine Sulphate)
- Erwinase (Asparaginase)
- Farydak (Panobinostat)
- Folotyn (Pralatrexate)
- Elotuzumab
- Jakafi (ruxolitinib)
- Mektovi (Binimetinib)
- Mab Campath (Alemtuzumab)
- Keytruda (pembrolizumab)
- Kyprolis Carfilzomib
- Lenalid (lenalidomide)
- Mylotarg (Gemtuzumab)
- Ninlaro
- Nplate (Romiplostin)
- Oncaspar (Pegaspargase)
- Pomalid (pomalidomide)
- Tepadina (Thiotepa)
- Tafinlar
- Velcade (bortezomib)
- Zelboraf (vemurafenib)
-
Leukemia
- Atriance (nelarabine)
- Besponsa (inotuzumab ozogamicin)
- Blincyto (Blinatumomab)
- Gleevec (Imatinib)
- Glivec (Imatinib)
- Synribo (omacetaxine mepesuccinate)
- Iclusig (ponatinib)
- Rydapt (midostaurin)
- Neupogen (Filgrastim Injection)
- Tarceva (Erlotinib)
- Tasigna (Nilotinib)
- Veenat (Imatinib Mesylate)
- Venclexta (venetoclax tablets)
- Vyxeos (Daunorubicin and Cytarabine)
- Zydelig (idelalisib)
- Lymphoma
- Blood Cancer
-
Multiple Melanoma
- Asthama
- Bone Marrow
- Brain Tumor
- Cardiology
- Crohn's disease
- Diabetes
- Fungal Disease
- Gastroenterology
- Heart Disease
- Dermatology
- Multiple Sclerosis
- Kidney
- Rheumatoid Arthritis
- Weight Management
-
Others
- Cymevene (Ganciclovir)
- Gutron (midodrine)
- Ilaris (canakinumab)
- Kanuma (sebelipase-alfa)
- Reblozyl (luspatercept-aamt)
- Soliris eculizumabeculizumab)
- Somavert (pegvisomant)
- Unituxin (dinutuximab)
- Vistide (Cidofovir)
- Vitrakvi (larotrectinib)
- Xadago (safinamide)
- Xermelo (telotristat ethyl)
- Zostavax (zoster vaccine live)
-
Medical Oncology
- Available In IndiaFDA Approved
- Testimonials
- Channel PartnerApply Now
- FAQ
- News/Updates
- Events
- Blog
Indian Pharma Network
For Urgent Support
24/7 Free Support
Call US
+91 9891296838 / 9811747774
Oncology Drugs Approved for Liver Cancer
If you have an enquiry about the FDA approved anti-cancer drugs / medicines approved by the Food and Drug Administration (FDA) for Liver Cancer treatment. To get access in India or overseas please call M: +91 9891296838 / 9811747774 at India Standard Time (IST) or email us in details about your requirement at info@indianpharmanetwork.co.in. Our customer support team always ready to help you, they will support you 24/7.
